Plant Biotech Co. Phyton Buys Chemotherapy Patents
Positioning itself to become a leading provider of certain common chemotherapy agents, plant culture technology company Phyton Biotech LLC announced Monday that it had purchased the intellectual property and other assets...To view the full article, register now.
Already a subscriber? Click here to view full article